SCHEMBL6686885

SCHEMBL6686885

C[Si](C)(C)CCOCn1nc(CCCC(N)=O)c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.47
PADI4 Q9UM07 1/20 0.39
KDM4E B2RXH2 3/20 0.36
SLC16A3 O15427 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
EGFR P00533 1/20 0.34
IGF1R P08069 1/20 0.34
SRC P12931 1/20 0.34
FLT4 P35916 1/20 0.34
KDR P35968 1/20 0.34
FLT3 P36888 1/20 0.34
EPHB4 P54760 1/20 0.34
TEK Q02763 1/20 0.34
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
REN P00797 1/20 0.33
IDE P14735 1/20 0.33
LMNA P02545 3/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14158232 0.81 NPC1 (0.43) NPC1KDM4ESLC16A3SMN1; SMN2EGFR
SCHEMBL14699371 0.80 NPC1 (0.54) NPC1
SCHEMBL29921411 0.80 NPC1 (0.37) NPC1PADI4SLC16A3EGFRIGF1R
SCHEMBL28381362 0.78 NPC1 (0.42) NPC1KDM4ESMN1; SMN2EGFRIGF1R
SCHEMBL14158477 0.77 PDE5A (0.40) NPC1KDM4ESLC16A3SMN1; SMN2EGFR
SCHEMBL23908827 0.77 NPC1 (0.43) NPC1KDM4ESLC16A3SMN1; SMN2EGFR
SCHEMBL23908911 0.76 MAPT (0.45) NPC1SLC16A3TSHRHSD17B10AKR1B1
SCHEMBL30142294 0.76 NPC1 (0.47) NPC1SMN1; SMN2TSHRHPGDKMT2A
SCHEMBL30142296 0.76 NPC1 (0.47) NPC1SMN1; SMN2TSHRHPGDKMT2A
SCHEMBL4109728 0.76 NPC1 (0.45) NPC1KDM4ESMN1; SMN2EGFRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487804-A2 AMINOINDAZOLE DERIVATIVES AS PROTEIN-KINASE INHIBITORS Aventis Pharma S.A. (FR) 2004-12-22 EP disclosed
WO-2003078403-A2 DERIVES D’AMINOINDAZOLES COMME INHIBITEURS DE PROTEINE-KINASE AVENTIS PHARMA S.A. (FR) 2003-09-25 WO disclosed